A stagewise response to mitochondrial dysfunction in mitochondrial DNA maintenance disorders.
Biochim Biophys Acta Mol Basis Dis
2024
1870
5
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
J Neurol
2024
271
6
3702-3707
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
J Neurol
2024
271
1
141-176
B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4.
Nature
2024
627
8003
407-415
Optical coherence tomography angiography suggests different retinal pathologies in multiple sclerosis and Sjögren's syndrome.
J Neurol
2024
271
7
4610-4619
msqrob2PTM: Differential Abundance and Differential Usage Analysis of MS-Based Proteomics Data at the Posttranslational Modification and Peptidoform Level.
Mol Cell Proteomics
2024
23
2
Proteomic studies in VWA1-related neuromyopathy allowed new pathophysiological insights and the definition of blood biomarkers.
J Cell Mol Med
2024
28
8
Rapamycin rescues loss of function in blood-brain barrier-interacting Tregs.
JCI Insight
2024
9
7
Retinal small vessel pathology is associated with disease burden in multiple sclerosis.
Mult Scler
2024
30
7
812-819
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
Lancet Reg Health Eur
2024
39